U.S., Jan. 29 -- ClinicalTrials.gov registry received information related to the study (NCT06796673) titled 'Retina BioBank: Retina Biomarkers for a Deeper Understanding of Vitreoretinal and Systemic Diseases' on Feb. 22, 2023.
Brief Summary: The RBBK study is a non-interventional, prospective study that will characterize disease state biomarker levels from aqueous humor, vitreous humor, intraoperative tissue and saliva of subjects with various retinal and systemic pathologies.
Study Start Date: April 11, 2022
Study Type: OBSERVATIONAL
Condition:
Other Retinal Disorders
Retinal Disease
Retinal Vascular Disorder
Recruitment Status: ENROLLING_BY_INVITATION
Sponsor: Greater Houston Retina Research
Disclaimer: Curated by HT Syndication....